Compare the Outcomes of XT and XEC Adjuvant Chemotherapy in HER2-negative Luminal B Breast Cancer Patients

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified January 2013 by Guangdong Academy of Medical Sciences
Sponsor:
Collaborators:
Chinese Anti-Cancer Association
Guangzhou General Hospital of Guangzhou Military Command
Guangzhou First Municipal People’s Hospital
Information provided by (Responsible Party):
Liao Ning, Guangdong Academy of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01779531
First received: January 24, 2013
Last updated: January 28, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)